// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Suitability for low-dose rivaroxaban based on compass trial: a district general hospital perspective

Muhammad Asad - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

rivaroxaban

Developing stem cell-based models of foam cell formation to study new pathways of lipid clearance that regulate inflammation

Jenefa Begum - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Icosapent ethyl

TAM receptor AXL loss regulates smooth muscle cell differentiation and accelerates atherosclerosis in mice

Lucy Mcshane - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

L-Tyrosine

Harnessing the power of palmitoylation to tune NCX1 Physiology

Caglar Gok - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Tetracycline

Optimising culture of iPSC-derived cardiomyocytes on a pro-survival substrate

Annalisa Bettini - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Single cell transcriptomics reveals regenerative embryonic pathways lost in the adult epicardium

Vincent Knight-Schrijver - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Light sheet imaging to analyse the spatial distribution of proteins in atherosclerotic plaques

Ziqi Zhou - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

VSMC contribution to neointimal lesions arises from the clonal expansion of few primed cells

Matt Worssam - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Restenosis

N/A

The RAF ‘paradox breaker’ inhibitor, PLX8394, activates ERK1/2 in endothelial cells and promotes cardiac remodelling

Susanna Cooper - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Telomere damage promotes vascular smooth muscle cell senescence and immune cell recruitment after vessel injury

Mandy Grootaert - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Doxorubicin

Pontin regulates cardiac remodelling by modulating the hippo pathway in cardiomyocytes

Bayu Lestari - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Hypertrophic cardiomyopathy

Angiotensin II

Selective activation of primed vascular smooth muscle cells

Jordi Lambert - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Atherosclerotic lesions

N/A

Reprogramming human macrophages with drug X: potential mechanisms for stabilisation of atherosclerotic plaques

Klaudia Kocsy - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

IL-4

Mechanosensor piezo1 in skeletal muscle pericytes

Yilizila Abudushalamu - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Tamoxifen

Novel strategy using hesc-derived cardiomyocytes to explore the critical importance of the apelin receptor in the cardiovascular system

Robyn Macrae - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Tetracycline

Coherent vortex flow in the adult right atrium

Lian Gan - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Plasma desmosine as a biomarker in acute aortic syndrome

Maaz Syed - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Genetically-determined serum calcium levels influence markers of ventricular repolarisation: a mendelian randomisation study

William Young - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Regional alterations to the transverse-tubule network in an ovine model of myocardial infarction

Tharushi Perera - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Post-myocardial infarction

Digibind

A carvedilol analogue, VKII-86, prevents hypokalaemia-induced ventricular arrhythmia through novel multi-channel effects

Victoria Robinson - British Cardiovascular Society (BCS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Carvedilol

Copyright © 2026. QuantiNova All rights reserved